z-logo
open-access-imgOpen Access
Success factors in drug discovery and development
Author(s) -
Björn Wallmark
Publication year - 2017
Publication title -
advances in precision medicine
Language(s) - English
Resource type - Journals
eISSN - 2424-9106
pISSN - 2424-8592
DOI - 10.18063/apm.2016.02.002
Subject(s) - productivity , drug development , perspective (graphical) , business , drug discovery , microbiology and biotechnology , drug , engineering ethics , risk analysis (engineering) , engineering , medicine , pharmacology , computer science , economic growth , economics , biology , bioinformatics , artificial intelligence
The article aimed to give a personal perspective on drug discovery and development. The author has worked both in Big Pharma as a scientist and manager and more recently also in start-up biotech companies. Drug companies have played a major important role in improving population health and will continue to do so. The hurdles and costs for drug development have continuously risen without a parallel enhancement of productivity. There is no single explanation for this and the article outlines success factors and hurdles for effective drug development. Aspects of the external and internal environments that influence Big Pharma productivity is outlined and discussed.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom